EquityZen Growth Technology Fund LLC - Series 1248
Raised
$408K
Investors
22
Min Invest
$10,080
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1248 is a Delaware pooled investment fund offering filed by EquityZen Advisors LLC that raised $408K from 22 investors with a $10K minimum investment under Rule 506(b) and Section 3(c)(1). This is an amended filing dated June 15, 2022, part of the EquityZen platform, which operates 1889+ related pre-IPO SPV series structures.
This pre-IPO pooled investment vehicle follows the standard EquityZen platform template: Rule 506(b) and 3(c)(1) exemptions with accessible $10K minimums targeting retail-accredited investors. The investor count (22) and modest raise size ($408K) reflect typical SPV economics for single-company secondary share aggregation, consistent with the EquityZen operational model across nearly 2,000 series vehicles.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
